Question 1

How many shares of MLTX does RTW INVESTMENTS, LP own?

Accepted Answer

RTW INVESTMENTS, LP previously held 0 shares of MLTX (MoonLake Immunotherapeutics Class A) before exiting the position in 2025-Q3.

Question 2

What is RTW INVESTMENTS, LP's MLTX position worth?

Accepted Answer

RTW INVESTMENTS, LP's MLTX position was last reported at $0 in 2025-Q3 before the exit.

Question 3

Is RTW INVESTMENTS, LP buying or selling MLTX?

Accepted Answer

In 2025-Q3, RTW INVESTMENTS, LP exited their MLTX position entirely (-100.0% change in shares).

Question 4

When did RTW INVESTMENTS, LP first buy MLTX?

Accepted Answer

Based on available 13F filings, RTW INVESTMENTS, LP first reported a position in MLTX in 2022-Q2. They have held the position across 9 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$6.24	0
2025-Q2	New	741,090	-	$35M	0.5%	$47.52	48
2023-Q4	Exited	0	-100.0%	$0	0.0%	$60.39	0
2023-Q3	Unchanged	500,000	0.0%	$28.5M	0.6%	$57.00	0
2023-Q2	Unchanged	500,000	0.0%	$25.5M	0.5%	$51.08	0
2023-Q1	Unchanged	500,000	0.0%	$10.7M	0.2%	$21.85	0
2022-Q4	Unchanged	500,000	0.0%	$5.3M	0.1%	$10.50	0
2022-Q3	Unchanged	500,000	0.0%	$3.9M	0.1%	$7.98	0
2022-Q2	New	500,000	-	$2.6M	0.1%	$5.00	36

MLTX9 quarters

MLTX
9 quarters